Community voices: meet Yasmine
Yasmine is a member of the Patient and Public Network and a Cochrane US Year 4 trainee. Yasmine began by contributing to plain language summaries through Cochrane Engage and is now part of a global research project. She shares where this had lead.
School feeding programs lead to modest but meaningful results
Free or subsidized school meals lead to modest gains in math and school enrolment, according to a new Cochrane review that examined the global impact of school feeding programs on disadvantaged children in both high-income countries and low- and middle-income countries.
New evidence questions the benefit of calcium supplements in pregnancy for preventing pre-eclampsia
An updated Cochrane review has found that calcium supplementation has no effect on pre-eclampsia, challenging long-held assumptions about the role of calcium in preventing hypertensive disorders in pregnancy.
New research confirms HPV vaccination prevents cervical cancer
Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.
What do we know about the HPV vaccine?
Learn about HPV as we answer common questions and explore how vaccination can protect children.
Guyane joined Cochrane through a local project with Cochrane Canada. Our Patient and Public Involvement Manager, April English, sat down with Guyane to talk about motivations to getting involved, the impact it’s had, top tips, and much more.
Call for proposals: AI tools to transform evidence synthesis
Cochrane invites proposals from AI tool developers to participate in a pilot initiative aimed at transforming how we produce and share high-quality evidence syntheses. This is an exciting opportunity to collaborate with a globally trusted organization in health research and contribute to the future of systematic reviews.
How can public health professionals overcome vaccine hesitation?
Vaccination against human papillomavirus (HPV) is one of the most effective tools for preventing cervical cancer in women and other HPV-associated diseases in people of all genders. Yet many people worldwide remain reluctant to take the vaccine.
Global evidence highlights social roots of HPV vaccine hesitancy
Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access
Common gout drug may reduce risk of heart attack and stroke
A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.
News
News
The Cochrane Collaboration is a charity (no. 1045921) and a company limited by guarantee (no. 03044323) registered in England & Wales. VAT registration number GB 718 2127 49.